Jordana Joy, Editor

Nate Lighthizer, OD, FAAO, offers practical advice for clinicians adopting YAG capsulotomy.

Nathan Lighthizer, OD, FAAO, presented on laser trabeculoplasty for glaucoma management at this year's conference.

Mile Brujic, OD, FAAO, presented data from a study in February 2026 that examined real-world experience with lifitegrast across 12 offices—6 ophthalmology and 6 optometry practices.

Inder Paul Singh, MD, emphasized that patient compliance is a real and significant challenge in glaucoma care.

Learn the latest on legislative updates from Arkansas, Texas, South Carolina, and Pennsylvania.

Rachon, OD, FAAO, DipABO, details her SECO 2026 poster presentation, "Treatment of Stage 1 NK Secondary to Acoustic Neuroma Removal with Cryopreserved Amniotic Membrane."

Cathleen McCabe, MD, details what can be done now for these patients in a sea of imperfect options.

A handful of MDs detail their presentations at this year's conference.

Rahul S. Tonk, MD, MBA, discussed his session on dry eye disease at EnVision Summit 2026, and looked ahead at the pipeline of therapies in development.

Pathik Amin, OD, FAAO, gave a presentation to the optometry cohort at the conference on glaucoma management, focusing on surgical options and recent advancements.

Julia Pulliam, OD, FAAO, highlights how working in an academic medical center provides significant advantages for managing complex conditions like uveitis.

McCabe, MD, presented alongside P. Dee Stephenson, MD, FACS, for the product theater titled "Know Your Dry Eye: Navigating the Challenges of Real-World Dry Eye Cases."

Pathik P. Amin, OD, FAAO, details his segment of an educational track session on glaucoma at this year's conference.

Jade Coats, OD, FAAO, and Cecelia Koetting, OD, FAAO, DipABO, provide a sneak peek into their 2-day session at the conference.

Cecelia Koetting, the EnVision Summit chair for optometry, OD, FAAO, DipABO, gave a sneak peak into the CE and networking opportunities at the conference.

In recent months, developments have ranged from regulatory setbacks to real-world data releases.

Derek N. Cunningham, OD, FAAO, details candidate selection, mechanism of action, and patient education for the new eye drop.

Formerly known as Brimochol PF, the dual-agent eye drop is now the first and only of its kind for the treatment of presbyopia in adults.

Bisant A. Labib, OD, FAAO, DipAAO, gives her insights on the causes and management of anterior uveitis during Island Eyes 2026.

Benjamin P. Casella, OD, FAAO, shares perspectives on the most impactful glaucoma developments from the past year and the future role of interventional and personalized care.

Keeping a pulse on current developments has helped optometrists look to the future

ODs are gearing up for anticipated advancements in specialty lens and lenses for myopia management and patients with astigmatism.

Kuzniar's OGSLS 2026 poster presentation provides a follow-up to previous fitting findings for the Zenlens Chroma HOA lens.

Jason Jedlicka, OD, FAAO, talks through a presentation he gave during last week's conference.

Previously, the EDOF technology was specifically limited to intraocular lenses.

Susan Gromacki, OD, MS, FAAO, FSLS, details her presentation given at this year's conference.

Jamie Kuzniar, OD, FAAO, FSLS, details a poster presentation that served as a follow-up to results of previous fittings of Zenlens Chroma HOA (Bausch + Lomb).

Jason Jedlicka, OD, overviews his poster, “A Custom Wavefront-Guided Scleral Lens System For Higher Order Aberrations: Real-World Early Experience From a Retrospective Multicenter Case Review.”

New clinical data and trial updates closed out 2025.